- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 20:00 | Upstream Bio stock rallies 32% following upsized $255M IPO | 1 | Seeking Alpha | ||
| 19:49 | Upstream Bio Shares Rise 26% to Lead Burst of Life Sciences IPOs | 1 | BNN Bloomberg | ||
| 18:58 | Upstream Bio valued at $1.1 billion as shares jump in Nasdaq debut | 1 | Reuters | ||
| 14:31 | Respiratory disorder biotech Upstream Bio prices upsized IPO at $17 high end | 1 | Renaissance Capital | ||
| 12:30 | Upstream Bio Prices Upsized 15M Share IPO at $17/sh | 1 | Investing.com | ||
| 07:30 | Upstream Bio prices IPO at $17 per share | 1 | Seeking Alpha | ||
| 05:18 | Upstream Bio Prices Upsized IPO Of 15 Mln Shares At $17.00/shr | 363 | AFX News | WASHINGTON (dpa-AFX) - Upstream Bio Inc. (UPB) announced the pricing of its upsized initial public offering of 15 million shares of its common stock at a public offering price of $17.00 per... ► Artikel lesen | |
| 03:49 | Upstream Bio Leads Three Life Sciences IPOs With Upsized Listing | 1 | BNN Bloomberg | ||
| 02:22 | Upstream Bio raises $255 million in US IPO | 1 | Reuters | ||
| 01:42 | Upstream Bio Announces Pricing of Upsized Initial Public Offering | 26 | GlobeNewswire (Europe) | WALTHAM, Mass., Oct. 10, 2024 (GLOBE NEWSWIRE) -- Upstream Bio, Inc. (Nasdaq: UPB), a clinical-stage biotechnology company developing treatments for inflammatory diseases, with an initial focus on... ► Artikel lesen | |
| Di | Upstream Bio, CeriBell, CAMP4 set terms for proposed IPOs | 1 | Seeking Alpha | ||
| Di | Upstream Bio, Inc. - 8-A12B, Registration of securities | 2 | SEC Filings | ||
| Mo | Respiratory disorder biotech Upstream Bio sets terms for $200 million IPO | 2 | Renaissance Capital | ||
| Mo | Upstream Bio Files for 12.5M Share IPO at $15-$17/sh | 1 | Investing.com | ||
| Mo | Upstream Bio, Inc. - S-1/A, General form for registration of securities | 2 | SEC Filings | ||
| 18.09. | Respiratory disorder biotech Upstream Bio files for a $100 million IPO | 4 | Renaissance Capital | ||
| 18.09. | Upstream Bio, Inc. - S-1, General form for registration of securities | 2 | SEC Filings |
17 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| QIAGEN | 40,130 | +0,01 % | Neue 7,50% Aktienanleihe mit Barriere auf QIAGEN in Zeichnung | München (www.anleihencheck.de) - Die Experten vom Zertifikate-Team der Bank Vontobel Europe AG bieten eine neue Aktienanleihe (ISIN DE000VC37J66/ WKN VC37J6) mit Barriere auf die Aktie von QIAGEN (ISIN... ► Artikel lesen | |
| ADMA BIOLOGICS | 17,395 | +2,26 % | Dow flat, S&P 500 and Nasdaq dip; ADMA Biologics slumps 20%, DJT eyes best week since March | ||
| EVOTEC | 5,640 | +0,62 % | Evotec Aktie: Tauziehen zwischen Trendwende und nächstem Kurssturz | Für die Evotec Aktie gab es auch im Feiertagshandel am Donnerstag nichts zu holen. Auf XETRA-Schlusskursbasis ging es um mehr als 2 Prozent nach unten auf 5,99 Euro - das waren ganze 2 Cent mehr als... ► Artikel lesen | |
| LONGBOARD PHARMACEUTICALS | 38,800 | +12,89 % | Longboard Pharmaceuticals, Inc.: Longboard Pharmaceuticals to Present Late-Breaking and Encore Data at the 15th European Epilepsy Congress | Longboard Pharmaceuticals, Inc. (Nasdaq: LBPH), a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases, today announced that it... ► Artikel lesen | |
| SUMMIT THERAPEUTICS | 19,640 | +5,59 % | (SMMT) - Analyzing Summit Therapeutics' Short Interest | ||
| BIONTECH | 109,40 | +1,77 % | BioNTech, Mynaric, Pentixapharm, TUI, Verbio, Vonovia - 4investors Aktien Top-News | Wo ist am Aktienmarkt etwas los, welche Themen interessieren Anleger derzeit besonders? Vor allem für Trader ist es wichtig zu wissen, wo "die Musik spielt" und welche Themen an der Börse aktuell besonders... ► Artikel lesen | |
| NURIX THERAPEUTICS | 23,415 | +7,02 % | Unveiling 6 Analyst Insights On Nurix Therapeutics | ||
| AVIDITY BIOSCIENCES | 45,540 | +2,99 % | Avidity Biosciences' drug cleared by FDA | ||
| EDGEWISE THERAPEUTICS | 30,230 | +0,77 % | Edgewise Therapeutics (NASDAQ:EWTX) Trading Up 4.5% After Analyst Upgrade | ||
| RECURSION PHARMACEUTICALS | 6,605 | +6,96 % | Recursion, Exscientia seek support for merger ahead of special meeting | ||
| MODERNA | 53,56 | +3,02 % | Exxon Mobil, Gold, Apple, Amazon, Pfizer, Las Vegas Sands, Moderna | Bisher läuft es für die Wall Street im Oktober alles andere als rund. Am Freitag verzeichneten die großen Indizes zwar Gewinne, die Tage davor waren allerdings durchwachsen. Und auch heute deutet sich... ► Artikel lesen | |
| JANUX THERAPEUTICS | 48,610 | +2,94 % | Janux Therapeutics, Inc. (JANX): A Hot Stock to Buy Now | ||
| SPRINGWORKS THERAPEUTICS | 30,230 | -0,36 % | SpringWorks Therapeutics, Inc.: FDA Grants Priority Review to SpringWorks Therapeutics' New Drug Application for Mirdametinib for the Treatment of Adults and Children with NF1-PN | - PDUFA target action date of February 28, 2025 - - EU Marketing Authorization Application also validated by European Medicines Agency - STAMFORD, Conn., Aug. 28, 2024 (GLOBE NEWSWIRE) -- SpringWorks... ► Artikel lesen | |
| HARMONY BIOSCIENCES | 34,900 | +0,29 % | Analyst sees 24% upside for Harmony Biosciences stock as it maintains outperform rating | ||
| ANNEXON | 7,330 | +4,56 % | Annexon Biosciences: Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4) | BRISBANE, Calif., Aug. 16, 2024 (GLOBE NEWSWIRE) -- Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical company advancing novel complement therapies for neuroinflammatory diseases of the body, brain... ► Artikel lesen |
UPSTREAM BIO INC gehört der Branche Biotechnologie an. Mit einer aktuellen Kursveränderung von 0,000 (0,00 %) liegt der Kurs bei 22,640 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu UPSTREAM BIO INC finden Sie auf Wallstreet Online.
